Minerva Neurosciences (NERV) Other Non-Current Assets (2013 - 2021)
Minerva Neurosciences (NERV) reported Other Non-Current Assets of $14808.0 for Q2 2021, little changed on a YoY basis from $14808.0 in Q2 2020, and little changed quarter-over-quarter from $14808.0 in Q1 2021.
Minerva Neurosciences (NERV) Other Non-Current Assets (2013 - 2021) Analysis & Trends
Minerva Neurosciences has reported Other Non-Current Assets for 7 years, with the latest figure at $14808.0 in Q2 2021.
- For the quarter ending Q2 2021, Other Non-Current Assets changed 0.0% year-over-year to $14808.0; the trailing twelve-month figure through Jun 2021 stood at $14808.0 (changed 0.0% YoY), and the FY2020 full-year result was $14808.0, changed 0.0% from the prior year.
- Other Non-Current Assets for Q2 2021 stood at $14808.0, roughly flat from $14808.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $14808.0 in Q4 2017, with the low at $14808.0 in Q4 2017.
- Historically, Other Non-Current Assets has averaged $14808.0 across 5 years, with a median of $14808.0 in 2017.
- The largest YoY upside for Other Non-Current Assets was 0.0% in 2018 against a maximum downside of 0.0% in 2018.
- Minerva Neurosciences' Other Non-Current Assets stood at $14808.0 in 2017, then changed by 0.0% to $14808.0 in 2018, then changed by 0.0% to $14808.0 in 2019, then changed by 0.0% to $14808.0 in 2020, then changed by 0.0% to $14808.0 in 2021.
- The last three Other Non-Current Assets figures came in at $14808.0 (Q2 2021), $14808.0 (Q1 2021), and $14808.0 (Q4 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Minerva Neurosciences | 197.55 Mn | 197.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 14,808.00 |
| Mar 31, 2021 | 14,808.00 |
| Dec 31, 2020 | 14,808.00 |
| Sep 30, 2020 | 14,808.00 |
| Jun 30, 2020 | 14,808.00 |
| Mar 31, 2020 | 14,808.00 |
| Dec 31, 2019 | 14,808.00 |
| Sep 30, 2019 | 14,808.00 |
| Jun 30, 2019 | 14,808.00 |
| Mar 31, 2019 | 14,808.00 |
| Dec 31, 2018 | 14,808.00 |
| Sep 30, 2018 | 14,808.00 |
| Jun 30, 2018 | 14,808.00 |
| Mar 31, 2018 | 14,808.00 |
| Dec 31, 2017 | 14,808.00 |
| Jun 30, 2014 | 3.11 Mn |
| Dec 31, 2013 | 433,998.00 |